Electromedical Technologies Statistics
Want to see EMED full AI Analyst Report?
Electromedical Technologies (EMED) Stock Statistics & Valuation Metrics
Total Valuation
Electromedical Technologies has a market cap or net worth of $373.23K. The enterprise value is $1.21T.
- Market Cap
- $373.23K
- Enterprise Value
- $1.21T
Share Statistics
Electromedical Technologies has 3,732,294,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,732,294,200
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Electromedical Technologies’s return on equity (ROE) is 0.40 and return on invested capital (ROIC) is 42.78%.
- Return on Equity (ROE)
- 0.40
- Return on Assets (ROA)
- -1.67
- Return on Invested Capital (ROIC)
- 42.78%
- Return on Capital Employed (ROCE)
- 0.29
- Revenue Per Employee
- 6,865.833
- Profits Per Employee
- -239.98K
- Employee Count
- 6
- Asset Turnover
- 0.05
- Inventory Turnover
- 4.91
Valuation Ratios
The current PE Ratio of Electromedical Technologies is -0.22. Electromedical Technologies’s PEG ratio is 0.00.
- PE Ratio
- -0.22
- PS Ratio
- 13.59
- PB Ratio
- -0.09
- Price to FCF
- -0.68
- Price to Operating Cash Flow
- -0.68
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Electromedical Technologies had revenue of 41.20K and earned -1.44M in profits. Earnings per share was 0.00.
- Revenue
- 41.20K
- Gross Profit
- -62.18K
- Operating Income
- -1.02M
- Pretax Income
- -1.44M
- Net Income
- -1.44M
- EBITDA
- -915.91K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -549.57K and capital expenditures 6, giving a free cash flow of -549.56K billion.
- Operating Cash Flow
- -549.57K
- Free Cash Flow
- -549.56K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Electromedical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -147.24%
- Earnings Yield
- -461.49%
Stock Price Statistics
- Beta
- -11.80
- 52-Week Price Change
- -99.29%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Electromedical Technologies upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Nov 16, 2023
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Electromedical Technologies as a current ratio of 0.16, with Debt / Equity ratio of -34.29%
- Current Ratio
- 0.16
- Quick Ratio
- 0.16
- Debt to Market Cap
- 2.12
- Net Debt to EBITDA
- -0.88
- Interest Coverage Ratio
- -6.19
Taxes
In the past 12 months, Electromedical Technologies has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Electromedical Technologies EV to EBITDA ratio is -1.53, with an EV/FCF ratio of -2.98.
- EV to Sales
- 59.59
- EV to EBITDA
- -1.53
- EV to Free Cash Flow
- -2.98
- EV to Operating Cash Flow
- -2.98
Balance Sheet
Electromedical Technologies has $531.00 in cash and marketable securities with $1.26M in debt, giving a net cash position of -$1.26M billion.
- Cash & Marketable Securities
- $531.00
- Total Debt
- $1.26M
- Net Cash
- -$1.26M
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is -252.41%, with operating margin of -4165.36%, and net profit margin of -6271.25%.
- Gross Margin
- -252.41%
- Operating Margin
- -4165.36%
- Pretax Margin
- -6271.25%
- Net Profit Margin
- -6271.25%
- EBITDA Margin
- -3883.52%
- EBIT Margin
- -4154.72%
Analyst Forecast
The average price target for Electromedical Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -66.56%
- EPS Growth Forecast
- 69.23%
Scores
- Smart Score
- ―
- AI Score
- 34
